👋HCPs insights wanted
We’re exploring BCMA bispecific antibodies in RRMM
Is the following a gap in clinical practice?
HCPs lack standardised processes to safely initiate BCMA BsAb therapy, including patient selection, baseline assessment, logistics and consent